Attached files
file | filename |
---|---|
10-K - Tongli Pharmaceuticals (USA), Inc. | v189393_10-k.htm |
EX-31.2 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex31-2.htm |
EX-23.1 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex23-1.htm |
EX-32.1 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex32-1.htm |
EX-31.1 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex31-1.htm |
Exhibit
32.2
CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350
In
connection with the accompanying Annual Report on Form 10-K of Tongli
Pharmaceuticals (USA), Inc. for the period ended March 31, 2010, I, Li Li, Chief
Financial Officer, hereby certifies pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
1. Such
Annual Report on Form 10-K for the year ended March 31, 2010, fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and
2. The
information contained in such Annual Report on Form 10-K for the year ended
March 31, 2010, fairly presents, in all material respects, the financial
condition and results of operations of Tongli Pharmaceuticals (USA),
Inc.
Dated:
June 29, 2010
/s/
Li Li
|
|
Li
Li
|
|
Chief
Financial Officer
|